GlipiZIDE Extended-release Tablets, 2.5 mg, 30 Tablets (3 x 10), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC: 68084-295-21
Published May 8, 2019 · Recall initiated: April 8, 2019
Summary
FDA records drug Class II recall D-1276-2019, published May 8, 2019 and initiated April 8, 2019. Recalling firm: American Health Packaging; Status: Terminated; Reported quantity: 2,203 cartons (cartons of 30 individual unit doses); Lot: Lot # 181288, EXP 5/31/2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Specifications: dissolution failure at time zero of the repackaged lot. Drug release results were slightly above specification at time zero.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- American Health Packaging
- Distributor
- Nationwide in the USA
- Lot
- Lot # 181288, EXP 5/31/2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACyanocobalamin Injection, USP, 1,000 mcg/mL, Rx Only, 25 x 1mL -Multiple-Dose Vials per carton, Mfg. by:November 11, 2026
- FDAMetoclopramide Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only, Distributed by: American Health Packaging,October 21, 2026
- FDABuprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American HealthSeptember 9, 2026
- FDANitrofurantoin Capsules, USP (Monohydrate/Macrocrystals), 100 mg, 100 Capsules (10 x 10), 10-count blistersMay 25, 2022
- FDALosartan Potassium and Hydrochlorothiazide Tablets, USP, 100mg/25mg, a) 30-count (NDC: 13668-118-30) b)May 8, 2019
- FDAAji Amarillo Paste, in 40 lb buckets.May 8, 2019
Questions about this recall
Was GlipiZIDE Extended-release Tablets, 2.5 mg, 30 Tablets (3 x 10), Rx Only, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217. NDC: 68084-295-21 recalled?
Yes. FDA published recall D-1276-2019 on May 8, 2019. Reported hazard: Failed Dissolution Specifications: dissolution failure at time zero of the repackaged lot. Drug release results were slightly above specification at time zero.
What should I do if I have this product?
Voluntary: Firm initiated · Letter